Long-term blood pressure variability, new-onset diabetes mellitus, and new-onset chronic kidney disease in the Japanese general population

Hypertension

Volumn 66, Issue 1, 2015, Pages 30-36

  Yano, Yuichiro ^a   Fujimoto, Shouichi ^b   Kramer, Holly ^d   Sato, Yuji ^c   Konta, Tsuneo ^e   Iseki, Kunitoshi ^f   Iseki, Chiho ^f   Moriyama, Toshiki ^g   Yamagata, Kunihiro ^h   Tsuruya, Kazuhiko ⁱ   Narita, Ichiei ^j   Kondo, Masahide ^h   Kimura, Kenjiro ^k   Asahi, Koichi ^l   Kurahashi, Issei ^m   Ohashi, Yasuo ⁿ   Watanabe, Tsuyoshi ^l  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF MIYAZAKI   (Japan)

^c UNIVERSITY OF MIYAZAKI HOSPITAL   (Japan)

^d LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^e YAMAGATA UNIVERSITY   (Japan)

^f UNIVERSITY HOSPITAL OF THE RYUKYUS   (Japan)

^g OSAKA UNIVERSITY   (Japan)

^h UNIVERSITY OF TSUKUBA   (Japan)

ⁱ KYUSHU UNIVERSITY   (Japan)

^j NIIGATA UNIVERSITY   (Japan)

^k ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^l FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^m IAnalysis LLC   (Japan)

ⁿ CHUO UNIVERSITY   (Japan)

more..

Author keywords

blood pressure; chronic renal disease; diabetes mellitus; epidemiology

Indexed keywords

ANTIHYPERTENSIVE AGENT; GLUCOSE; LIPID; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGE; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE VARIABILITY; BODY MASS; CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEINURIA; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SMOKING; SYSTOLIC BLOOD PRESSURE; AGING; ANALYSIS; BLOOD; BLOOD PRESSURE; DIABETIC NEPHROPATHIES; EARLY DIAGNOSIS; GLUCOSE BLOOD LEVEL; JAPAN; MIDDLE AGED; ONSET AGE; PHYSIOLOGY; PROSPECTIVE STUDY; RENAL INSUFFICIENCY, CHRONIC;

ADULT; AGE OF ONSET; AGED; AGING; BLOOD GLUCOSE; BLOOD PRESSURE; DIABETES MELLITUS; DIABETIC NEPHROPATHIES; EARLY DIAGNOSIS; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTENSION; JAPAN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC;

EID: 84940093849     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.115.05472     Document Type: Article

References (30)

1. Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Ford CE, Shulman NB, Stamler J., Blood pressure and end-stage renal disease in men. N Engl J Med 1996 334 13 18. doi: 10.1056/NEJM199601043340103
2. Yano Y, Fujimoto S, Sato Y, Konta T, Iseki K, Moriyama T, Yamagata K, Tsuruya K, Yoshida H, Asahi K, Kurahashi I, Ohashi Y, Watanabe T., Association between prehypertension and chronic kidney disease in the Japanese general population. Kidney Int 2012 81 293 299. doi: 10.1038/ki.2011.346
3. Hill GS., Hypertensive nephrosclerosis. Curr Opin Nephrol Hypertens 2008 17 266 270. doi: 10.1097/MNH.0b013e3282f88a1f
4. Okada H, Fukui M, Tanaka M, Matsumoto S, Mineoka Y, Nakanishi N, Asano M, Yamazaki M, Hasegawa G, Nakamura N., Visit-To-visit blood pressure variability is a novel risk factor for the development and progression of diabetic nephropathy in patients with type 2 diabetes. Diabetes Care 2013 36 1908 1912. doi: 10.2337/dc12-2087
5. McMullan CJ, Lambers Heerspink HJ, Parving HH, Dwyer JP, Forman JP, de Zeeuw D., Visit-To-visit variability in blood pressure and kidney and cardiovascular outcomes in patients with type 2 diabetes and nephropathy: a post hoc analysis from the RENAAL study and the Irbesartan Diabetic Nephropathy Trial. Am J Kidney Dis 2014 64 714 722. doi: 10.1053/j.ajkd.2014.06.008
6. Kilpatrick ES, Rigby AS, Atkin SL., The role of blood pressure variability in the development of nephropathy in type 1 diabetes. Diabetes Care 2010 33 2442 2447. doi: 10.2337/dc10-1000
7. Yokota K, Fukuda M, Matsui Y, Hoshide S, Shimada K, Kario K., Impact of visit-To-visit variability of blood pressure on deterioration of renal function in patients with non-diabetic chronic kidney disease. Hypertens Res 2013 36 151 157. doi: 10.1038/hr.2012.145
8. Wei FF, Li Y, Zhang L, Xu TY, Ding FH, Wang JG, Staessen JA., Beat-To-beat, reading-To-reading, and day-To-day blood pressure variability in relation to organ damage in untreated Chinese. Hypertension 2014 63 790 796. doi: 10.1161/HYPERTENSIONAHA.113.02681
9. Parati G, Liu X, Ochoa JE., Clinical relevance of visit-To-visit blood pressure variability: impact on renal outcomes. J Hum Hypertens 2014 28 403 409. doi: 10.1038/jhh.2013.96
10. Parati G, Ochoa JE, Lombardi C, Bilo G., Assessment and management of blood-pressure variability. Nat Rev Cardiol 2013 10 143 155. doi: 10.1038/nrcardio.2013.1
11. Rothwell PM., Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension. Lancet 2010 375 938 948. doi: 10.1016/S0140-6736(10)60309-1
12. Chen W, Srinivasan SR, Yao L, Li S, Dasmahapatra P, Fernandez C, Xu J, Berenson GS., Low birth weight is associated with higher blood pressure variability from childhood to young adulthood: the Bogalusa Heart Study. Am J Epidemiol 2012 176 suppl 7 S99 S105. doi: 10.1093/aje/kws298
13. Yano Y, Ning H, Allen N, Reis JP, Launer LJ, Liu K, Yaffe K, Greenland P, Lloyd-Jones DM., Long-Term blood pressure variability throughout young adulthood and cognitive function in midlife: the Coronary Artery Risk Development in Young Adults (CARDIA) study. Hypertension 2014 64 983 988. doi: 10.1161/HYPERTENSIONAHA.114.03978
14. Faramawi MF, Delongchamp R, Said Q, Jadhav S, Abouelenien S., Metabolic syndrome is associated with visit-To-visit systolic blood pressure variability in the US adults. Hypertens Res 2014 37 875 879. doi: 10.1038/hr.2014.89
15. Yano Y, Fujimoto S, Sato Y, New-onset hypertension and risk for chronic kidney disease in the Japanese general population. J Hypertens 2014 32 2371 2377. doi: 10.1097/HJH.0000000000000344
16. Zemaitis P, Liu K, Jacobs DR Jr, Cushman M, Durazo-Arvizu R, Shoham D, Palmas W, Cooper R, Kramer H., Cumulative systolic BP and changes in urine albumin-To-creatinine ratios in nondiabetic participants of the multi-ethnic study of atherosclerosis. Clin J Am Soc Nephrol 2014 9 1922 1929. doi: 10.2215/CJN.02450314
17. Hastie CE, Jeemon P, Coleman H, McCallum L, Patel R, Dawson J, Sloan W, Meredith P, Jones GC, Muir S, Walters M, Dominiczak AF, Morrison D, McInnes GT, Padmanabhan S., Long-Term and ultra long-Term blood pressure variability during follow-up and mortality in 14,522 patients with hypertension. Hypertension 2013 62 698 705. doi: 10.1161/HYPERTENSIONAHA.113.01343
18. Horio M, Imai E, Yasuda Y, Watanabe T, Matsuo S., Modification of the CKD epidemiology collaboration (CKD-EPI) equation for Japanese: accuracy and use for population estimates. Am J Kidney Dis 2010 56 32 38. doi: 10.1053/j.ajkd.2010.02.344
19. Rifkin DE, Shlipak MG, Katz R, Fried LF, Siscovick D, Chonchol M, Newman AB, Sarnak MJ., Rapid kidney function decline and mortality risk in older adults. Arch Intern Med 2008 168 2212 2218. doi: 10.1001/archinte.168.20.2212
20. Parati G, Liu X, Ochoa JE, Bilo G., Prognostic relevance of blood pressure variability: role of long-Term and very long-Term blood pressure changes. Hypertension 2013 62 682 684. doi: 10.1161/HYPERTENSIONAHA.113.01801
21. Silacci P, Desgeorges A, Mazzolai L, Chambaz C, Hayoz D., Flow pulsatility is a critical determinant of oxidative stress in endothelial cells. Hypertension 2001 38 1162 1166
22. Chappell DC, Varner SE, Nerem RM, Medford RM, Alexander RW., Oscillatory shear stress stimulates adhesion molecule expression in cultured human endothelium. Circ Res 1998 82 532 539
23. Miao CY, Xie HH, Zhan LS, Su DF., Blood pressure variability is more important than blood pressure level in determination of end-organ damage in rats. J Hypertens 2006 24 1125 1135. doi: 10.1097/01.hjh.0000226203.57818.88
24. Aoki Y, Kai H, Kajimoto H, Kudo H, Takayama N, Yasuoka S, Anegawa T, Iwamoto Y, Uchiwa H, Fukuda K, Kage M, Kato S, Fukumoto Y, Imaizumi T., Large blood pressure variability aggravates arteriolosclerosis and cortical sclerotic changes in the kidney in hypertensive rats. Circ J 2014 78 2284 2291
25. Agrawal V, Marinescu V, Agarwal M, McCullough PA., Cardiovascular implications of proteinuria: an indicator of chronic kidney disease. Nat Rev Cardiol 2009 6 301 311. doi: 10.1038/nrcardio.2009.11
26. Levey AS, Inker LA, Matsushita K, Greene T, Willis K, Lewis E, de Zeeuw D, Cheung AK, Coresh J., GFR decline as an end point for clinical trials in CKD: a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration. Am J Kidney Dis 2014 64 821 835. doi: 10.1053/j.ajkd.2014.07.030
27. Li Z, Snieder H, Su S, Harshfield GA, Treiber FA, Wang X., A longitudinal study of blood pressure variability in African-American and European American youth. J Hypertens 2010 28 715 722. doi: 10.1097/HJH.0b013e328336ed5b
28. Kallianos A, Trakada G, Papaioannou T, Nikolopouloss I, Mitrakou A, Manios E, Kostopoulos K, Kostopoulos C, Zakopoulos N., Glucose and arterial blood pressure variability in Obstructive Sleep Apnea Syndrome. Eur Rev Med Pharmacol Sci 2013 17 1932 1937
29. Paulis L, Unger T., Novel therapeutic targets for hypertension. Nat Rev Cardiol 2010 7 431 441. doi: 10.1038/nrcardio.2010.85
30. Webb AJ, Rothwell PM., Effect of dose and combination of antihypertensives on interindividual blood pressure variability: a systematic review. Stroke 2011 42 2860 2865. doi: 10.1161/STROKEAHA.110.611566